| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sam Schlessinger | EVP General Counsel | 2026-02-21 | 510 | $11.84 | $6.04kSell |
| Paul Schwichtenberg | President and COO | 2026-02-21 | 566 | $11.84 | $6.70kSell |
| Ajay Patel | EVP and CFO | 2026-02-21 | 566 | $11.84 | $6.70kSell |
| Ajay Patel | EVP and CFO | 2026-02-18 | 1,377 | $11.87 | $16.34kSell |
| Paul Schwichtenberg | President and COO | 2026-02-18 | 1,377 | $11.87 | $16.34kSell |
| Sam Schlessinger | EVP General Counsel | 2026-02-18 | 1,239 | $11.87 | $14.71kSell |
| Paul Schwichtenberg | President and COO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| Sam Schlessinger | EVP General Counsel | 2026-02-07 | 619 | $12.74 | $7.89kSell |
| Ajay Patel | EVP and CFO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| David Matthew Stark | Director | 2025-11-10 | 8,959 | $0.76 | $6.81kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gavin Molinelli | 82.16% | 5,295,270 | $102.68M | Insider |
| Biovail Laboratories Inc | 65.82% | 4,242,032 | $82.25M | Insider |
| Kevin C. Tang | 59.23% | 3,817,600 | $74.02M | Insider |
| James A. Schoeneck | 13.85% | 892,840 | $17.31M | Insider |
| Arthur J. Higgins | 11.52% | 742,239 | $14.39M | Insider |
| Nantahala Capital Management LLC | 9.11% | 587,335 | $11.39M | Institution |
| Peter D. Staple | 7.81% | 503,295 | $9.76M | Insider |
| John N. Shell | 7.76% | 500,258 | $9.70M | Insider |
| William McKee | 5.37% | 346,280 | $6.71M | Insider |
| Julian N. Stern | 5.30% | 341,666 | $6.62M | Insider |